Amit Kumar, Ph.D.
Chairman, President and CEO
ITUS Corporation (NASDAQ:ITUS)
Parent of Alumnae: Anika Kumar 2017 and Anissa Kumar 2019
ND Board Member Term:
July 2018 – June 2021
Board Committee: Investment
Dr. Kumar is an experienced research scientist, executive and investor, who has founded, built, run, and invested in a number of biotechnology enterprises. Over the last 25 years, Dr. Kumar has either performed or managed research programs in both cancer diagnostics and therapeutics. Over the last 20 years, he has helped his private and publicly listed companies raise over $500 Million dollars.
In addition to his commercial activities, Dr. Kumar sits on the National Board of the American Cancer Society.
Currently, Dr. Kumar is the Chairman, President and CEO of ITUS Corporation (NASDAQ:ITUS), a cancer diagnostic and therapeutic company. Previously, Dr. Kumar was CEO of GFF, a privately held biotech company. Before that, Dr. Kumar was President and CEO of CombiMatrix Corporation (CBMX:NASDAQ), a position he held from 2001 to 2010. CBMX was a cancer and genetic diagnostic company that Dr. Kumar took public. CBMX was recently acquired by Invitae (NASDAQ:NVTA).
Dr. Kumar is currently Chairman of another public company, and Chairman and founder of two private companies. Dr. Kumar has also held positions at Venture Capital Firms (Oak Investment Partners, Acacia Research Corp.) and Biotech firms IDEXX Laboratories (IDXX:NASDAQ), Signature BioSciences (sold), Tacere Therapeutics (sold), Idetek Corporation (sold), and others.
He has also been an advisor or consultant to Fortune 500 companies, venture capital firms, private equity funds, and private early stage healthcare companies. He has 40 peer-reviewed technical publications and holds seventeen patents with others pending.
Dr. Kumar also has extensive experience working with the US government. He has presented to individual members and committees of the US House of Representatives and Senate as well as White House Staff. He has also worked with various defense agencies as well as the US FDA.
Dr. Kumar holds an AB with honors in Chemistry from Occidental College. Following post-graduate studies at both Stanford University and the California Institute of Technology, he received his Ph.D. in Physical Chemistry from the California Institute of Technology. Dr. Kumar also completed a post-doctoral fellowship at Harvard University.
Dr. Kumar is a US citizen and lives in Northern California with his physician wife and two teenage daughters.
One of his daughters, Anika Kumar, graduated from Notre Dame in 2017 and is beginning her sophomore year at U.C. Berkeley. His other daughter, Anissa Kumar, is going into her senior year at Notre Dame and is a member of the class of 2019.